Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
236
datasets available to search
ShareScore release 0.7.1
Dataset results
236 results for “Immune Thrombocytopenia”
A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT03395210. IPD Sharing: YES. Countries: 8. Publications: 4.
Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT04562766. IPD Sharing: YES. Countries: 26. Publications: 3.
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
ClinicalTrials.gov study NCT04278924. IPD Sharing: YES. Countries: 11. Publications: 0.
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
ClinicalTrials.gov study NCT01444417. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia
ClinicalTrials.gov study NCT01349790. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)
ClinicalTrials.gov study NCT01438840. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim
ClinicalTrials.gov study NCT01143038. IPD Sharing: Not stated. Countries: 9. Publications: 4.
V-IMMUNE® for Immune Thrombocytopenia
ClinicalTrials.gov study NCT06962631. IPD Sharing: NO. Countries: 1. Publications: 3.
Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
ClinicalTrials.gov study NCT06817395. IPD Sharing: YES. Countries: 1. Publications: 3.
Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT02279173. IPD Sharing: YES. Countries: 17. Publications: 2.
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
ClinicalTrials.gov study NCT03939637. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia
ClinicalTrials.gov study NCT04214951. IPD Sharing: NO. Countries: 1. Publications: 13.
A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).
ClinicalTrials.gov study NCT04188379. IPD Sharing: NO. Countries: 18. Publications: 1.
Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT03771378. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
ClinicalTrials.gov study NCT01520909. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months
ClinicalTrials.gov study NCT04516967. IPD Sharing: NO. Countries: 9. Publications: 1.
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT03275454. IPD Sharing: YES. Countries: 3. Publications: 1.
A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura
ClinicalTrials.gov study NCT01071954. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
ClinicalTrials.gov study NCT05653219. IPD Sharing: YES. Countries: 24. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
ClinicalTrials.gov study NCT04687072. IPD Sharing: UNDECIDED. Countries: 32. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.